FindTrial
Sign In

External-beam radiation

RADIATION3 trials

Sponsors

Zhujiang Hospital, Peking University Third Hospital, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Conditions

Cervical Adenosquamous Cell CarcinomaCervical Squamous Cell CarcinomaCervical Squamous Cell Carcinoma in SituNeoplasmsRectal CancerStage IB Cervical CancerStage IIA Cervical CancerStage IIB Cervical Cancer

Phase 2

Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
NCT03469531
Zhujiang HospitalCervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma in Situ, Neoplasms +5
Start: 2018-03-20End: 2021-12-30Target: 100Updated: 2018-08-13
Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer
RecruitingNCT05136326
Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRectal Cancer
Start: 2021-12-01End: 2026-12-31Target: 21Updated: 2023-03-01

Unknown Phase

Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma
NCT04678791
Peking University Third HospitalCervical Squamous Cell Carcinoma
Start: 2020-12-31End: 2025-12-31Target: 286Updated: 2020-12-22

Related Papers

Nimotuzumab plus concurrent chemoradiotherapy for locally advanced cervical squamous cell carcinoma: The randomized, phase 3 CC3 study.
Journal of Clinical Oncology2024-06-013 citations